Verrica Pharmaceuticals Inc

Healthcare · Biotechnology

4.10$ -1.7% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Verrica Pharmaceuticals Inc (VRCA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 36 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VRCA
Line item	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	0.5	–	–	–	9.1	29	105	99	92	86	81	76	68	94	87	80	74	108	99	89	80	72	63	49	45	69	62	97	82	66	52	33	54	42	39	41	47	39	36
Current Assets	0.5	0.5	–	–	9.1	29	105	99	91	85	80	74	65	91	83	74	68	102	93	83	74	66	57	43	39	63	57	92	78	61	47	28	51	39	37	36	43	33	33
Cash	0.5	-0.5	–	–	8.7	27	103	38	10	24	20	11	9.2	54	49	17	11	44	25	20	16	10	5.4	32	34	60	55	84	70	49	32	23	46	30	15	21	30	21	11
Cash & Short-Term Investments	–	0.5	–	–	8.7	27	103	97	90	83	79	71	62	88	80	72	65	88	90	79	70	22	14	39	34	60	55	84	70	49	32	23	46	30	15	21	30	21	11
Receivables	–	–	–	–	–	–	–	–	–	0.0	–	–	–	–	–	–	–	12	–	–	–	0.4	0.2	0.4	0.5	0.1	0.2	4.1	4.4	7.6	10	0.1	0.1	5.7	17	7.3	5.4	7.8	11
Inventory	–	–	–	–	–	–	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.0	–	-0.5	–	–	0.3	1.0	2.5	2.7	2.6	2.5	2.5	2.5	2.3	2.2	2.0	2.7
Property, Plant & Equipment	–	–	–	–	–	0.0	0.1	0.1	0.3	1.3	1.5	2.0	2.2	2.4	2.5	2.7	4.9	3.3	5.4	3.7	3.9	4.2	4.0	4.0	3.9	3.8	5.0	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	–	–	–	–	–	–	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	0.4	–	–	–	16	1.6	3.1	2.5	2.5	3.2	4.4	4.4	3.4	38	39	41	41	46	47	48	48	46	47	4.4	4.7	3.8	6.8	55	62	65	65	67	64	61	57	58	22	23	32
Current Liabilities	0.4	–	–	–	0.6	1.6	3.1	2.5	2.5	3.1	4.3	4.3	3.4	3.3	39	39	39	45	45	46	46	45	46	3.1	3.5	2.6	5.7	11	17	19	20	21	29	29	29	29	16	16	22
Short-Term Debt	0.0	0.0	–	–	0.0	0.0	–	–	–	0.1	0.1	0.1	0.1	0.1	35	35	36	41	41	42	42	42	43	0.3	0.3	0.3	0.3	0.3	0.7	1.0	1.1	1.2	14	13	13	13	0.7	0.7	1.0
Accounts Payable	0.1	–	–	–	0.2	0.6	1.1	1.1	1.0	1.1	1.5	1.0	1.2	1.1	1.3	0.2	0.3	0.9	0.8	0.9	0.8	0.5	0.7	0.1	0.5	0.6	2.1	1.9	2.5	2.5	1.2	1.0	1.9	1.4	2.3	1.6	2.1	2.2	1.6
Long-Term Debt	–	–	–	–	–	–	0.0	0.0	–	0.2	–	–	–	34	–	–	35	–	–	–	–	–	–	–	–	–	–	42	43	43	43	43	31	28	25	22	–	–	–
Shareholders' Equity	0.1	0.1	–	–	-7.0	28	102	96	89	83	77	72	65	57	48	39	33	62	52	41	33	25	16	45	40	65	55	42	20	1.5	-13	-34	-9.9	-19	-17	-17	25	16	4.3
Retained Earnings	-2.7	–	–	–	-12	-14	-20	-27	-33	-40	-47	-54	-61	-71	-80	-91	-104	-105	-117	-129	-139	-147	-158	-158	-163	-170	-181	-206	-230	-251	-268	-291	-307	-317	-317	-317	-325	-335	-348
Shares Outstanding	–	2.6	2.6	2.6	2.0	2.2	2.2	2.5	2.5	2.5	2.5	2.5	2.5	2.5	2.5	2.5	2.5	2.6	2.8	2.8	2.8	2.8	2.8	4.5	4.1	4.3	4.6	4.6	4.6	4.6	4.7	4.7	6.7	9.5	9.5	9.5	11	21	21

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings